1. Delamater L, Santoro N. Management of the Perimenopause. Clin Obstet Gynecol 2018;61(3):419-32.
2. Paramsothy P, Harlow SD, Greendale GA, et al. Bleeding patterns during the menopausal transition in the multi-ethnic Study of Women’s Health Across the Nation (SWAN): a prospective cohortstudy. BJOG 2014;121(12):1564-73.
3. Goldstein SR, Lumsden MA. Abnormal uterine bleeding in perimenopause. Climacteric 2017;20(5):414-20.
4. Lethaby A, Farquhar C, Cooke I. Antifibrinolytics for heavy menstrual bleeding. Cochrane Database Syst Rev 2000;(4):CD000249.
5. Lethaby A, Shepperd S, Cooke I, et al. Endometrial resection and ablation versus hysterectomy for heavy menstrual bleeding. Cochrane Database Syst Rev 2000;(2):CD000329.
6. Hale GE, Robertson DM, Burger HG. The perimenopausal woman: endocrinology and management. J Steroid Biochem Mol Biol 2014;142:121-31.
7. Sharma J, Tiwari S. Hysteroscopy in Abnormal Uterine Bleeding vs Ultrasonography and Histopathology Report in Perimenopausal and Postmenopausal Women. J Nepal Med Assoc 2016;55(203):26-8.
8. Querleu D, Darai E, Lecuru F, et al. Prise en charge primaire des cancers de l’endomètre : recommandations SFOG-CNGOF. Gynécologie Obstétrique Fertilité & Sénologie 2017;45(12):715-25.
9. Long ME, Faubion SS, MacLaughlin KL, et al. Contraception and hormonal management in the perimenopause. J Womens Health (Larchmt) 2015;24(1):3-10.
10. Plu-Bureau G, Sabbagh E, Hugon-Rodin J. Contraception hormonale et risque vasculaire. RPC Contraception CNGOF. Gynécologie Obstétrique Fertilité & Sénologie 2018;46(12):823-33.